Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2

The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.

[1]  T. Notomi,et al.  Loop-mediated isothermal amplification of DNA. , 2000, Nucleic acids research.

[2]  Howard Newman,et al.  Lessons in diagnostic virology: expected and unexpected sources of error , 2019, Reviews in medical virology.

[3]  Kwok-Hung Chan,et al.  Consistent Detection of 2019 Novel Coronavirus in Saliva , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. D. de Rie,et al.  Research Techniques Made Simple: High-Throughput Sequencing of the T-Cell Receptor. , 2017, The Journal of investigative dermatology.

[5]  Aviv Regev,et al.  Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.

[6]  V. Pelechano,et al.  Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform , 2020, Clinical chemistry.

[7]  Wei Zhang,et al.  Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes , 2020, Emerging microbes & infections.

[8]  Y. Teo,et al.  Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review , 2020, Journal of clinical medicine.

[9]  Mario Plebani,et al.  Laboratory abnormalities in patients with COVID-2019 infection , 2020, Clinical chemistry and laboratory medicine.

[10]  Anders Wolff,et al.  2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics , 2020, Micromachines.

[11]  Mario Plebani,et al.  A Six-Sigma approach for comparing diagnostic errors in healthcare-where does laboratory medicine stand? , 2018, Annals of translational medicine.

[12]  J M Hughes,et al.  Emerging infectious diseases: public health issues for the 21st century. , 1999, Science.

[13]  Calvin J Chiew,et al.  Interrupting transmission of COVID-19: lessons from containment efforts in Singapore , 2020, Journal of travel medicine.

[14]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[15]  Marc D Porter,et al.  SERS as a bioassay platform: fundamentals, design, and applications. , 2008, Chemical Society reviews.

[16]  Jose Lourenco,et al.  Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR , 2020, medRxiv.

[17]  Hao Feng,et al.  A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT , 2020, Japanese Journal of Radiology.

[18]  Xin Li,et al.  Rapid colorimetric detection of COVID-19 coronavirus using a reverse tran-scriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic plat-form: iLACO , 2020, medRxiv.

[19]  M. Blaser,et al.  Critical role of nosocomial transmission in the toronto sars outbreak. , 2004, Mathematical biosciences and engineering : MBE.

[20]  P. Vollmar,et al.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.

[21]  G. Lippi,et al.  Building a bridge to safe diagnosis in health care. The role of the clinical laboratory , 2016, Clinical chemistry and laboratory medicine.

[22]  Jonathan E. Schmitz,et al.  Laboratory Diagnosis of COVID-19: Current Issues and Challenges , 2020, Journal of Clinical Microbiology.

[23]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.

[24]  Yung-Chih Wang,et al.  Point-of-Care RNA-Based Diagnostic Device for COVID-19 , 2020, Diagnostics.

[25]  M Plebani,et al.  Mistakes in a stat laboratory: types and frequency. , 1997, Clinical chemistry.

[26]  J. Maeng,et al.  Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) , 2020, The Journal of Molecular Diagnostics : JMD.

[27]  A. Vincent,et al.  Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine. , 2014, Methods in molecular biology.

[28]  P. Horby,et al.  A novel coronavirus outbreak of global health concern , 2020, The Lancet.

[29]  Duncan Graham,et al.  Simultaneous detection and quantification of three bacterial meningitis pathogens by SERS , 2014 .

[30]  K. Yong,et al.  A Review on Functionalized Gold Nanoparticles for Biosensing Applications , 2011 .

[31]  Shibo Jiang,et al.  A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV , 2018, Viruses.

[32]  T. F. Smith,et al.  Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing , 2006, Clinical Microbiology Reviews.

[33]  A. Šimundić,et al.  The EFLM strategy for harmonization of the preanalytical phase , 2017, Clinical chemistry and laboratory medicine.

[34]  Xuguang Li,et al.  Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system , 2017, Scientific Reports.

[35]  Qi Zhao,et al.  Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 , 2020, International journal of biological sciences.

[36]  Chuan Qin,et al.  From SARS to MERS, Thrusting Coronaviruses into the Spotlight , 2019, Viruses.

[37]  Gheyath K Nasrallah,et al.  Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar , 2019, Journal of immunology research.

[38]  Jun Liu,et al.  Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing , 2020, Radiology.

[39]  Shaoqiang Li,et al.  Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis , 2020, Journal of medical virology.

[40]  M. Plebani.  Errors in clinical laboratories or errors in laboratory medicine? , 2006, Clinical chemistry and laboratory medicine.

[41]  Sandeep Kumar Vashist,et al.  In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends , 2020, Diagnostics.

[42]  G. Lippi,et al.  Estimating the intra- and inter-individual imprecision of manual pipetting , 2017, Clinical chemistry and laboratory medicine.

[43]  N. Beeching,et al.  Covid-19: testing times , 2020, BMJ.

[44]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[45]  Hadi Shafiee,et al.  Applications of gold nanoparticles in virus detection , 2018, Theranostics.

[46]  G. Lippi,et al.  A manifesto for the future of laboratory medicine professionals. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[47]  Carol Glaser,et al.  Laboratory Testing for Middle East Respiratory Syndrome Coronavirus, California, USA, 2013–2014 , 2015, Emerging infectious diseases.

[48]  S. Baek,et al.  Development of Reverse Transcription Loop-mediated Isothermal Amplification (RT-LAMP) Assays Targeting SARS-CoV-2 , 2020, bioRxiv.

[49]  Christopher Dye,et al.  After 2015: infectious diseases in a new era of health and development , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[50]  T. Burki.  Testing for COVID-19 , 2020, The Lancet Respiratory Medicine.

[51]  Q. Tao,et al.  Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases , 2020, Radiology.

[52]  R. Lu,et al.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.

[53]  Timothy F. Leslie,et al.  Complexity of the Basic Reproduction Number (R0) , 2019, Emerging infectious diseases.

[54]  M. Hong,et al.  Toward Flexible Surface‐Enhanced Raman Scattering (SERS) Sensors for Point‐of‐Care Diagnostics , 2019, Advanced science.

[55]  J. Noh,et al.  Covid-19 in South Korea — Challenges of Subclinical Manifestations , 2020, The New England journal of medicine.

[56]  C. Sheridan,et al.  Coronavirus and the race to distribute reliable diagnostics , 2020, Nature Biotechnology.

[57]  Yan Bai,et al.  Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.

[58]  B. Bosch,et al.  Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[59]  S. Payne.  Methods to Study Viruses , 2017, Viruses.

[60]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[61]  M. Wang,et al.  Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection , 2017, Scientific Reports.

[62]  Qingxi Wang,et al.  Rapid Detection of SARS-CoV-2 Using Reverse transcription RT-LAMP method , 2020, medRxiv.

[63]  N. Linton,et al.  Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases , 2020, Journal of clinical medicine.

[64]  X. Meng,et al.  Antigenic Cross-Reactivity between the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus and Polyclonal Antisera of Antigenic Group I Animal Coronaviruses: Implication for SARS Diagnosis , 2004, Journal of Clinical Microbiology.

[65]  G. Chowell,et al.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[66]  A. Šimundić,et al.  PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials , 2019, Clinical chemistry and laboratory medicine.

[67]  F. Kibenge,et al.  Diagnosis of Aquatic Animal Viral Diseases , 2016 .

[68]  Junhong Zhang,et al.  Alert to Potential Contagiousness: A Case of Lung Cancer With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection , 2020, Journal of Thoracic Oncology.

[69]  D. Gravel,et al.  Late Recognition of SARS in Nosocomial Outbreak, Toronto , 2005, Emerging infectious diseases.

[70]  Zi-feng Yang,et al.  Rapid and sensitive detection of COVID-19 using CRISPR/Cas12a-based detection with naked eye readout, CRISPR/Cas12a-NER , 2020, Science Bulletin.

[71]  Yuyi Wang,et al.  Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures , 2020, Journal of medical virology.

[72]  B. Tan,et al.  Outcome and Distal Access Patency in Subintimal Arterial Flossing with Antegrade-Retrograde Intervention for Chronic Total Occlusions in Lower Extremity Critical Limb Ischemia. , 2020, Journal of vascular and interventional radiology : JVIR.

[73]  N. Tanner,et al.  Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP , 2020, medRxiv.

[74]  Computed Tomographic Imaging of 3 Patients With Coronavirus Disease 2019 Pneumonia With Negative Virus Real-time Reverse-Transcription Polymerase Chain Reaction Test , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[75]  M. Trau,et al.  Duplex Microfluidic SERS Detection of Pathogen Antigens with Nanoyeast Single-Chain Variable Fragments , 2014, Analytical chemistry.

[76]  Marc D Porter,et al.  Prospects for point-of-care pathogen diagnostics using surface-enhanced Raman scattering (SERS). , 2016, Chemical Society reviews.

[77]  R. Parreira.  Laboratory Methods in Molecular Epidemiology: Viral Infections , 2018, Microbiology spectrum.

[78]  J. Nie,et al.  Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 , 2020, Emerging microbes & infections.

[79]  Dasheng Li,et al.  False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of Deep-Learning-Based CT Diagnosis and Insights from Two Cases , 2020, Korean journal of radiology.

[80]  R. Joshi,et al.  Hospital Based Infectious Disease Related Proportional Mortality Study , 2014, Journal of global infectious diseases.